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Introduction : Heparin-induced thrombocytopenia 
(HIT) is a not uncommon complication of heparin 
administration.There are two types of HIT.The 
first type is a mild transient thrombocytopenia 
of early onset.The patients are usually symptom- 
free,the thrombocytopenia usually improves and 
requires no therapy.The second type is a severe 
thrombocytopenia of delayed onset.This second 
type has the potential of serious thromboembolic 
complications (eg pulmonary embolism)(l).This 
type of thrombocytopenia requires treatment and 
heparin has to be stopped.The mechanism of this 
second type seems to be immune mediated.When 
patients with immune mediated HIT are rechallen- 
ged with heparin within 12 months of the initial 
event,recurrent thrombocytopenia and/or thrombo- 
sis may occur. We were presented with a patient 
requiring elective aortocoronary bypass surgery 
who had developed immune mediated HIT nine months 
before the anticipated date of surgery.Baemato- 
logical investigation suggested that heparinoid 
Org 10172 should be a safe alternative to heparin 
anticoagulation for cardiopulmonary bypass (CPB) 
in this patient, 
Methods : We obtained informed consent from the 
patient.Preoperatively the plasma of the patient 
demonstrated heparin-induced platelet aggregation 
in vitro as measured by standard platelet aggrego 
-metry.Additional in vitro aggregation studies 
with low-molecular-weight-heparins and heparinoids 
demonstrated that heparinoid Org 10172 produced 
the least aggregation.In vivo testing of Org 10172 
did not induce thrombocytopenia or disseminated 
intravascular coagulation (DIG) in this patient. 
Therefore Org 10172 was utilized to achieve anti- 
coagulation for CPB.The patient was given 10.000 
anti-Xa units of Org 10172 intravenously (at time 
TO) and 2.500 anti-Xa units were added to the 
priming fluid,Every hour on CPB an additional 
bolus of 1.250 antiiXa units of Org 10172 should 
be given in order to maintain a proper level of 
anticoagulation during CPB.Haemodynamic para - 
meters,whole blood platelet count,thrombin time 
(TT),activated partial thromboplastin time (aPTT) 
and prothrombin time (?T) were measured immedia- 
tely after induction of anaesthesia (T-30'),5 
minutes before (T-5') and after (T+5') the first 
administration of Org 10172 (TO),and at T+30', 
T+55',T+69',T+79',T+90',T+97',T+127' and at one 
hour intervals after surgery,the first and second 
postoperative day (PCD).Fibrinogen levels,anti- 
thrombin III activity (ATIII),factor V activity 
(fV),antiplasmin activity (AP),fibrinogen degra- 
dation products (FDP) and the ethanol gelation 
test were also measured at these time intervals. 
Results : Intravenous injection of 10.000 anti-Xa 
Units of Grg 10172 did not cause cardiovascular 
problems.At T+5':platelet count,fibrinogen level, 
ATIII,fV and AP did not change significantly in 
respect to the values of these parameters at T-5' 
aPTT increased by 96%,TT increased by 5346 and PT 
increased by 36$.At T+lZ' CPB was instituted 
without problems.At T+30' there was a "normal" 
decrease of the platelet count;aPTT,TT and PT 
remained elevated;fibrinogen level,ATIII,fV and 
AP were decreased by an amount which can be 
attributed to hemodilution.At T+57' 1.250 anti-Xa 
units of Org 10172 were given via the CPB circuit 
as dictated by the protocol.At T+75' however,and 
despite that aPTT,TT and PT were still prolonged, 
the surgeon observed some clots in the peri - 
cardial cavity.Therefore an additional bolus of 
1.250 anti-Xa units of Org 10172 was given via 
the CPB circuit.At T+90' CPB was terminated 
without problems and transfusion of packed cells 
(PC) and fresh frozen plasma (FFP) was started. 
No protamine was administered.At T+lZO' surgery 
was terminated and the patient was transferred 
to the postoperative care unit (POCU) in a stable 
haemodynamic condition.The first two hours in the 
POCU were characterized by excessive bleeding. 
Blood loss was compensated by transfusions of PC 
and FFP.The platelet count returned to subnormal 
level.aPTT,TT,PT,fibrinogen level,ATIII,fV and AP 
returned to normal values probably because of the 
administration of FFP,There was a thrombocyto - 
penia on the first POD (70.10e9/1) and on the 
second POD (46.10e9/1).From the fourth POD the 
platelet count gradually returns to normal values. 
Discussion : Heparinoid Org 10172 is a sulphated 
mucopolysaccharide from pig intestinal mucosa. 
Org 10172 has an anti-Xa/anti-thrombin ratio 
between 80 and lOO.Although it is claimed that 
Org 10172 is virtually devoid of anti-thrombin 
activity and does not have an effect upon blood 
platelet function,we did observe a prolongation 
of the aPTT and TT,and a postoperative thrombo- 
cytopenia.Furthermore the anticoagulation for 
CPB with Org 10172 is unpredictable as the sur - 
geon observed some clots in the pericardial 
cavity after the second bolus of Org 10172. 
Conclusion : We demonstrated that anticoagulation 
for CPB can be achieved with Org 10172,Because 
the above-mentioned problems .we cannot,however, 
recommend Org 10172 as a safe alternative for 
heparin anticoagulation for CPB in patients in 
whom heparin is relatively contra-indicated. 
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